Product category:
Clinical chemistry analysis
News Release from: Bespak Europe
Edited by the Laboratorytalk Editorial
Team on 06 November 2002
Formulation scientist appointed
Will be involved in testing and developing a range of valve options for pulmonary drug delivery in conjunction with pharmaceutical customers
Bespak, a developer of drug delivery systems, has announced the appointment of formulation scientist Susy Boswell to work in its science and technology Group Susy, who joins Bespak from 3M, is tasked with extending the company's knowledge of the drug/device interface to accelerate its development of technologies for pharmaceutical dosing
This article was originally published on Laboratorytalk on 14 Oct 2003 at 8.00am (UK)
Related stories
It gets right up your nose
Next generation nasal device is capable of delivering an accurate single dose of a wide range of therapeutic agents
Bespak welcomes European approval of Exubera
Bespak, in conjunction with Nektar Therapeutics, has developed the manufacturing process for Exubera's inhalation device which it will manufacture at its purpose designed facility in Milton Keynes
This appointment demonstrates Bespak's commitment to the delivery of leading-edge solutions for pharmaceutical manufacturers that go beyond the simple manufacturing of devices.
It highlights the company's continued momentum in growing its R and D team to help pharmaceutical companies bring a wider range of inhaled medicines to market.
"Bespak's aim is to work more closely with design engineers to provide advice on drug formulations and hardware/material interactions to optimise valve designs for a range of PMDI products," said Paul Taylor, chief technology officer at Bespak.
Further reading
B+O and Bespak build next generation inhaler
Bang and Olufsen Medicom and Bespak collaborate on next generation inhaler; the Assist Actuated Inhaler features integrated dose counter and easy-to-operate mechanism
Successful trial data supports better patient care
Bespak has announced further data to support the unique characteristics of its Easi-fill pressurised metered dose inhaler (pMDI) valve
"As a leading scientist on pharmaceutical delivery methods, Susy has an excellent insight into this technology and her expertise is directly related to Bespak's core market segments.
Her strong research and advisory skills provide the perfect combination to help keep Bespak ahead of its competitors." Susy Boswell will be involved in testing and developing a range of valve options for pulmonary drug delivery in conjunction with Bespak's pharmaceutical customers.
She will work to establish new materials and robust manufacturing processes that will enable Bespak and its customers to extend their expertise and take the delivery of inhaled drugs to the next level.
"I'm delighted to be joining a company that has so much synergy with my own technical interests," said Susy Boswell.
"Bespak's track record of innovative developments and its core scientific and materials skills combined with its understanding of regulatory affairs offers pharmaceutical and biotechnology companies an excellent opportunity to turn cutting-edge ideas into practical applications for its customers." Bespak's science and technology group was formed to increase the company's existing knowledge of the science behind drug delivery.
A team comprising material and formulation scientists, plastics and rubber specialists and rapid prototyping and design engineers is driving research and development forward in this field making Bespak a valued partner in the pursuit of innovative drug delivery solutions.
Bespak is establishing a new research facility for this work at its Milton Keynes establishment.
• Bespak Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
